Active — Not RecruitingNot Applicable

Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation

United States1,000 participantsStarted 2017-05-11

Plain-language summary

This is a registry study examining patients with HCC undergoing liver transplantation including outcomes and predictors of recurrence

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients (age\>18 years) undergoing Liver transplant for hepatocellular carcinoma Exclusion Criteria: * Patients under 18 years old * Patients who do not have hepatocellular carcinoma * patients who have hepatocellular carcinoma but do not undergo liver transplantation

What they're measuring

Recurrence Free Survival

Timeframe: From date of surgery to date of identified cancer recurrence through either clinical judgement or scans. This is assessed up to 10 years after the surgery.

Overall Survival

Timeframe: From date of surgery to date of death, up to 10 years after the surgery.

Trial details

NCT IDNCT06018857

SponsorFederico Aucejo

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2028-12

View on ClinicalTrials.gov More Hepatocellular Carcinoma trials